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Surface Coatings Determine Cytotoxicity and
Irritation Potential of Quantum Dot Nanoparticles
in Epidermal Keratinocytes
Jessica P. Ryman-Rasmussen1, Jim E. Riviere1 and Nancy A. Monteiro-Riviere1
Quantum dot (QD) nanoparticles have potential applications in nanomedicine as drug delivery vectors and
diagnostic agents, but the skin toxicity and irritation potential of QDs are unknown. Human epidermal
keratinocytes (HEKs) were used to assess if QDs with different surface coatings would cause differential effects
on HEK cytotoxicity, proinflammatory cytokine release, and cellular uptake. Commercially available QDs of two
different sizes, QD 565 and QD 655, with neutral (polyethylene glycol (PEG)), cationic (PEG-amine), or anionic
(carboxylic acid) coatings were utilized. Live cell imaging and transmission electron microscopy were used to
determine that all QDs localized intracellularly by 24 hours, with evidence of QD localization in the nucleus.
Cytotoxicity and release of the proinflammatory cytokines IL-1b, IL-6, IL-8, IL-10, and tumor necrosis factor-a
were assessed at 24 and 48 hours. Cytotoxicity was observed for QD 565 and QD 655 coated with carboxylic
acids or PEG-amine by 48 hours, with little cytotoxicity observed for PEG-coated QDs. Only carboxylic acid-
coated QDs significantly increased release of IL-1b, IL-6, and IL-8. These data indicate that QD surface coating is
a primary determinant of cytotoxicity and immunotoxicity in HEKs, which is consistent across size. However,
uptake of QDs by HEKs is independent of surface coating.
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INTRODUCTION
Semiconductor nanocrystals, or quantum dots (QDs) have
great potential for use as drug delivery, diagnostic, and
imaging agents in biomedicine and as semiconductors in the
electronics industry. QDs are a diverse class of engineered
nanostructures that are highly variable in chemical composi-
tion, size, and shape and are frequently multi-layered. The
center is comprised of a heterogeneous, colloidal core of
inorganic atoms (e.g., CdSe, CdTe, InAs, GaN) that is
frequently surrounded by a shell or ‘‘cap’’, such as ZnS, that
can reduce leaching of core metals (Derfus et al., 2004) and
attenuate fluorescence intermittency, or ‘‘blinking’’ (Nirmal
et al., 1996). Surface coatings in one or more layers are
often applied to the core/shell complex to customize QDs
for different applications, such as increased solubility in
biological media or bioconjugation to antibodies or
receptor ligands for ‘‘targeted’’ drug delivery and diagnostics
(Michalet et al., 2005). Nanoscale materials possess novel
properties as a direct consequence of size. This may have
unique consequences for toxicology (Monteiro-Riviere and
Ryman-Rasmussen, 2006). The hallmark nanoscale property
of QDs is quantum confinement, in which the distance
between an excited electron in the conduction band and the
corresponding vacant hole in the valence band (the ‘‘Bohr
radius’’) is greater than the size of the nanocrystal core, which
results in fluorescence at size-dependent wavelengths. The
excitation range of QDs is broad but the fluorescence is
discreet and resistant to photobleaching, making QDs easily
detectable and amenable to multicolor imaging studies and
tracking in live cells.
A seminal study demonstrated that targeted CdSe core/ZnS
shell QDs could be internalized by HeLa cells and tracked in
live cells for more than 10 days with no morphological signs
of toxicity (Jaiswal et al., 2003). This study fueled a great deal
of optimism that QDs were non-toxic at doses suitable for
long-term imaging studies and drug delivery. Therefore, many
synthetic efforts were focused in these directions. There are
increasing reports of QD cytotoxicity in the literature
(Hardman, 2006), none of which address skin. Recently, we
reported that exposure of skin to commercially available QDs
differing in core/shell shape, hydrodynamic size, and surface
coatings resulted in the penetration of the intact stratum
corneum barrier with localization of QDs in the underlying
epidermal and dermal layers as early as 8 hours after topical
application (Ryman-Rasmussen et al., 2006). This indicated
that skin is a potential route of exposure to QDs.
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The present study utilized primary human neonatal
epidermal keratinocytes (HEKs), an established in vitro model
for epidermal toxicity, to determine the cytotoxic and
inflammatory potential of QDs in skin. This study was
designed to test the hypothesis that QDs would be
differentially taken up by HEKs and cause cytotoxicity and
inflammatory cytokine release in a manner dependent on
surface coating. Soluble QDs of two sizes, QD 565 and QD
655, were obtained from a single, commercial source. Both
QD 565 and QD 655 were obtained with three different
surface coatings: polyethylene glycol (PEG), PEG-amines, or
carboxylic acids. We used laser scanning confocal micro-
scopy of live keratinocytes and transmission electron micro-
scopy (TEM) to verify QD uptake 24 hours after
administration. Cytotoxicity was assessed by cell viability
assays with thiazolyl blue tetrazolium bromide (3-[4,5]di-
methylthiazol-2,5 dephenyltetrazolium bromide (MTT))
at 24 and 48 hours. Inflammatory potential was assessed at
24 and 48 hours by measuring the release of the proin-
flammatory cytokines IL-1b, IL-6, IL-8, IL-10, and tumor
necrosis factor-a that are often used as markers for cutaneous
irritation.
RESULTS
Laser scanning confocal microscopy of QDs in live HEKs at
24 hours
We observed no overlap in the emission channels for QD 565
(green) and QD 655 (red) in trials with fixed keratinocytes
treated with 2 nM QD 565 or QD 655, which indicated that
dual-label imaging experiments were valid at this concentra-
tion, and autofluorescence in the absence of QDs was
negligible (data not shown). QDs of both sizes and all
coatings were localized intracellularly by 24 hours (Figure 1).
Punctate staining of PEG-coated QD 565 and QD 655
(Figure 1, top row) was observed in the cytoplasm, at the
periphery of the nucleus, and in the nucleus (QD 565). There
was no evidence of PEG-coated QD 565 and QD 655
colocalization (orange), although there were instances of
individual cells that contained both green and red punctae.
Approximately 50% of HEK cells in any visual field contained
PEG-coated QDs. PEG-amine-coated QD 565 and QD 655
(Figure 1, middle row) were observed as very large green (QD
565) or red (QD 655) punctae in the cytoplasm. PEG-amine-
QD-treated cells contained QD 565 or QD 655, QD 565 and
QD 655 in separate regions of the same cell, or colocalized
QD 565 and QD 655 (orange). Staining for PEG-amine-
coated QD 565 and QD 655 was sporadic, as the majority of
HEK cells in the culture dishes did not stain. Carboxylic acid-
coated QD 565 and QD 655 demonstrated very different
patterns of cytoplasmic localization than QDs coated with
PEG or PEG-amines (Figure 1, bottom row). A majority of
cells throughout the culture dish demonstrated diffuse,
punctate, staining for both QD 565 and QD 655, with large
and discrete punctae containing colocalized QD 565 and
QD 655 (orange). Intranuclear staining of carboxylic acid-
coated QD 565 and QD 655 was also observed.
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Figure 1. Uptake of QDs by live keratinocytes at 24 hours. HEKs were treated for 24 hours with QD 565 and QD 655 of the same coating (PEG, PEG-NH2,
or COOH) at a final concentration of 2 nM each and were imaged by live cell laser scanning confocal microscopy. Columns (left to right) show the DIC
channel, QD 565 emission channel, QD 655 emission channel, and an overlay of all three channels. Rows indicate QD coating. QD 565 are pseudo-colored
green, QD 655 are pseudo-colored red, and colocalized QD 565 and QD 655 are orange. Bar¼25 mM. Data are representative of three similar,
independent experiments.
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TEM of QDs in HEKs at 24 hours
QDs of both sizes and all coatings were intracellularly
localized by 24 hours. In all cases, QDs were usually found
agglomerated, both in membrane-bound, vacuolar compart-
ments (Figure 2a) or free in the cytoplasm (Figure 2b).
Occasionally with the PEG and PEG-amine-coated QD 565,
we observed lipid droplets that were peppered with QDs in
the interior and more dense along the periphery (Figure 2c).
We also observed several instances for PEG-coated QD 565
and QD 655 and carboxylic acid-coated QD 565 in which
QDs were agglomerated within the intranuclear region of the
cells. (Figure 2d).
MTT cell viability assays at 24 and 48 hours
No effects of 5% (v/v) borate vehicle of pH 8.3 or 9.0 were
seen on HEK viability at 24 or 48 hours (Figure 3a).
No differences in HEK viability were observed for three
concentrations of PEG-coated QD 565 at 24 or 48 hours
(Figure 3b). No differences were observed for PEG-coated
QD 655 at 24 hours. At 48 hours, however, there was a
moderate (20%) but significant decrease in MTT viability at
20 nM compared to vehicle-treated controls and lower
concentrations.
No differences in viability at any of the three concentra-
tions were observed for PEG-amine-coated QD 565 at
24 hours (Figure 3c). At 48 hours, however, viability de-
creased by 40% at the highest concentration compared to
vehicle-treated controls and lower concentrations. As cyto-
toxicity was present at 48 hours but not 24 hours, we
statistically compared viability at 24 and 48 hours at 20 nM
and found a significant effect of time on viability. Similarly, for
QD 655 coated with PEG-amine, there were no dose-
dependent differences in viability at 24 hours. However, at
48 hours, viability at 20 nM was decreased to 40% compared
to vehicle-treated controls and lower concentrations. There
was also a significant effect of time on the cytotoxicity of PEG-
amine-coated QD 655 at 20 nM between 24 and 48 hours.
Unlike QD 565 coated with PEG or PEG-amines, there
were significant differences in HEK viability at 24 hours for
carboxylic acid-coated QD 565 (Figure 3d). HEKs treated at
the highest of the three concentrations (20 nM) showed a 40%
decrease in viability compared to vehicle-treated controls
and lower concentrations. These differences remained at
48 hours. Similarly, QD 655 coated with carboxylic acids
decreased HEK viability by 40% at 24 hours compared to
vehicle-treated controls and lower concentrations. These
differences remained at 48 hours, where viability was
decreased by another 30%. This decrease in viability
between 24 and 48 hours was significant and indicated an
effect of time on cytotoxicity. As the decrease in viability
between 24 and 48 hours for carboxylic acid-coated QD 565
was smaller than QD 655, we conducted statistical compar-
isons to see if there was an effect of size on the cytotoxicity.
Comparison at 24 hours revealed no size differences. How-
ever, viability for QD 655 was significantly decreased relative
to QD 565 at 48 hours, indicating a modulatory role for size
in cytotoxicity.
Cytokines
For all detectable cytokines, there were no effects of 5% (v/v)
borate vehicle pH 8.3 or 9.0 at 24 or 48 hours.
IL-10 and tumor necrosis factor-a
IL-10 and tumor necrosis factor-a release were not detectable
for QD 565 and QD 655 of any coating at 24 or 48 hours
within the low range of the multiplex assay, which had a
threshold of 0.78 pg/ml.
IL-1b
The basal, control levels of IL-1b in the culture medium at
24 hours averaged 1.170.2 and 2.670.7 pg/ml at maximal
a
b
c
d
Figure 2. TEM of QD in keratinocytes at 24 hours. HEKs were treated for
24 hours with 2 nM QD 565 or QD 655 coated with PEG, PEG-amines, or
carboxylic acids. Arrows indicate QDs. (a) Example of QDs in a cytoplasmic
vacuole. Carboxylic acid-coated QD 655 is shown. (b) Example of
unsequestered QDs free in the cytoplasm. Note the vacuole (v) and
mitochondria (m). PEG-amine-coated QD 655 is shown. (c) Example
of lipid droplet (L) with QD staining along the periphery of the membrane.
PEG-coated QD 655 is shown. (d) Example of QD aggregates within
the nucleus. PEG-coated QD 655 is shown.
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response to QDs. Basal levels at 48 hours averaged 2.670.6
and 12.272.6 pg/ml at maximal response to QDs (data not
shown).
Effects of dose and coating on IL-1b release were observed
for QD 565. At 24 hours, there was over a 2-fold, dose-
dependent increase in IL-1b release for carboxylic acid-
coated QD 565 (Figure 4b). IL-1b release for this coating was
also significantly elevated compared to PEG and PEG-amine
coatings at either dose. These differences remained at
48 hours (Figure 4c). The magnitude of IL-1b release for
carboxylic acid-coated QD 565 did not change between 24
and 48 hours (Figure 4d).
Effects of coating and time on IL-1b release were observed
for QD 655. At 24 hours, there was over a 3-fold, dose-
dependent increase in IL-1b release for carboxylic acid-
coated QD 655 (Figure 4b). This was significantly elevated
compared to QD 655 coated with PEG or PEG-amines. At
48 hours, the magnitude of IL-1b release carboxylic acid-
coated QD 655 at the highest dose exceeded controls, the
lower dose, and other coatings by over 5-fold (Figure 4c).
Comparison of IL-1b levels for 20 nM carboxylic acid-coated
QD 655 at 24 and 48 hours revealed a significant effect of
time on the magnitude of IL-1b release for this coating and
dose (Figure 4d).
At 48 hours, the difference in IL-1b release for 20 nM
carboxylic acid-coated QD 655 and QD 565 was greater
than 2-fold (Figure 4c). Statistical analysis confirmed that this
difference was significant, revealing an effect of size on IL-1b
release.
IL-6
The basal, control levels of IL-6 in the culture medium at
24 hours averaged 110730 and 220780 pg/ml at maximal
response to QDs. Basal levels at 48 hours averaged 130750
and 260770 at maximal response to QDs (data not shown).
Effects of dose and coating were observed for QD 565. At
24 hours, IL-6 release for carboxylic acid-coated QD 565 at
20 nM was over 50% greater than control and the lower dose
(Figure 5b). At 48 hours, 20 nM carboxylic acid-coated QD
565 was elevated 2-fold compared to controls, the lower
dose, and PEG coating at either dose (Figure 5c). There was
also a slight but significant dose-dependent elevation in IL-6
release for 20 nM PEG-amine-coated QD 565 compared to
controls and the lower dose. IL-6 release for carboxylic acid-
coated QD 565 did not significantly differ between 24 and
48 hours (Figure 5d).
IL-6 release for QD 655 was dependent on dose, coating,
and time. Unlike QD 565, there were no effects of coating or
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Figure 3. MTT cell viability assays at 24 and 48 hours. (a) Effect of 5% (v/v) water or borate vehicle on MTT viability. (b–d) HEKs were treated with
5% (v/v) vehicle, QD 565, or QD 655 at 0.2, 2, or 20 nM. (b) PEG-coated QDs; (c) PEG-amine-coated QDs; and (d) Carboxylic acid-coated QDs. Lower
case a and b: Po0.05 compared to (a) vehicle-treated controls or (b) lower doses within each QD size. Lower case c and d: same, but at 48 hours. Upper
case A: an effect of time on viability between 24 and 48 hours when concentration and coating are held constant (Po0.05). Number 1: a significant effect
of size on viability when concentration, time, and coating are held constant (Po0.05).
146 Journal of Investigative Dermatology (2007), Volume 127
JP Ryman-Rasmussen et al.
Quantum Dot Interactions with Keratinocytes
concentration on IL-6 release for QD 655 at 24 hours (Figure
5b). However, significant differences were apparent at
48 hours (Figure 5c). Carboxylic acid-coated QD 655 at the
highest dose was elevated 2-fold compared to vehicle-treated
controls, the lower dose, and PEG and PEG-amine-coated
QD 655 at both doses. Comparison of the magnitude of IL-6
release for 20 nM carboxylic acid-coated QD 655 at 24 and
48 hours revealed a significant effect of time (Figure 5d).
The significant increase in IL-6 release at 24 hours for
20 nM carboxylic acid-coated QD 565 but not QD 655
indicated an effect of QD size on IL-6 release at 24 hours
(Figure 5b). This effect was confirmed by statistical compar-
ison. In contrast, at 48 hours, IL-6 release for carboxylic acid-
coated QD 565 and QD 655 did not significantly differ
(Figure 5c).
IL-8
The basal, control levels of IL-8 in the culture medium at
24 hours averaged 1,3007430 and 3,0007600 pg/ml at
maximal response to QDs. Basal levels at 48 hours averaged
1,4007140 and 2,8007480 pg/ml at maximal response to
QDs (data not shown).
Effects of dose and coating were observed for QD 565. At
24 hours, IL-8 release for 20 nM carboxylic acid-coated QD
565 was 2-fold greater than for vehicle-treated controls, the
lower dose, and PEG and PEG-amine coatings at either
concentration (Figure 6b). Forty-eight hours after treatment,
the magnitude of IL-8 release for 20 nM carboxylic acid-
coated QD 565 was unchanged (Figure 6d). Also, there was a
slight but significant, dose-dependent increase in IL-8 release
for 20 nM PEG-amine-coated QD 565 (Figure 6c).
Effects of coating, dose, and time on IL-8 release were
observed in response to QD 655. There were no effects of
coating or dose on IL-8 release for QD 655 at 24 hours (Figure
6b). By 48 hours, however, significant differences were
apparent. IL-8 release for carboxylic acid-coated QD 655 at
the highest dose was elevated over 2-fold compared to
vehicle-treated controls, the lower dose, and PEG and PEG-
amine-coatings at either dose. Also, there was a slight
but significant dose-dependent increase in IL-8 release for
20 nM PEG-amine-coated QDs. Comparison of IL-8 levels
for 20 nM carboxylic acid-coated QD 655 at 24 and
48 hours revealed a significant effect of time on IL-8 release
(Figure 6d).
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Figure 4. IL-1b release at 24 and 48 hours. (a) Effect of 5% (v/v) water or borate vehicle on IL-1b release at 24 hours. (b–d) HEKs were treated with 5% (v/v)
of vehicle, QD 565, or QD 655 coated with PEG, PEG-amines, or carboxylic acids at 0.2 or 20 nM. (b) Twenty four hours after QD treatment; (c) Forty eight
hours after QD treatment; and (d) effect of time on IL-1b release for QD 565 and QD 655 when concentration and coating are held constant. Lower
cases a–c: significant increase (Po0.05) in IL-1b release compared to (a) vehicle-treated controls, (b) the lower doses, or (c) other coatings within each QD
size. Number 1 represents a significant effect of QD size on IL-1b release when concentration, time, and coating are held constant (Po0.05). (d) An asterisk
denotes a significant effect of time on IL-1b release when concentration and coating are held constant.
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An effect of size on IL-8 release for 20 nM carboxylic acid-
coated QDs at 24 hours was indicated by the significant
increase in the release of this cytokine for QD 565 but not
QD 655 (Figure 6b). This effect was confirmed by statistical
comparison. However, this effect of size did not extend to
48 hours, at which time the magnitude of IL-8 release for
carboxylic acid-coated QD 565 and QD 655 did not differ
(Figure 6c).
DISCUSSION
We used commercially available CdSe core/ZnS shell QDs of
two sizes (QD 565 and QD 655) and three different surface
coatings (PEG, PEG-amines, and carboxylic acids) to test the
hypothesis that QDs would be differentially taken up by HEKs
and cause cytotoxicity and inflammatory cytokine release
depending on surface coating. We controlled for potential
core-related effects by restricting these studies to QDs
of the same core material with defined sizes and surface
coatings. We found that all QDs tested localized to the
interior of HEKs by 24 hours. However, cytotoxicity and
proinflammatory cytokine release were dependent up surface
coating, a robust finding consistent across QDs of two
different sizes (Table 1).
Previously, we reported that multi-walled carbon nano-
tubes were intracellularly localized in cytoplasmic vacuoles
of HEKs (Monteiro-Riviere et al., 2005b). The present study is
the first to determine that a similar phenomenon extends to
QDs in HEKs. Live cell imaging that eliminates fixation
artifacts was used in conjunction with confocal laser
scanning microscopy for this purpose. A low (2 nM), non-
cytotoxic concentration of QDs was chosen to minimize
uptake attributable to cell damage. All QDs localized
intracellularly by 24 hours, which was surprising because
these QDs were not ‘‘targeted’’ for cellular delivery. No
evidence of colocalization was seen for QD 565 and QD 655
coated with PEG, which indicates that QDs with the same
coating, but different core sizes, are differentially trafficked in
HEKs. This result is consistent with a previous study, which
showed that core size can influence the intracellular
localization of QDs with the same coating (Lovric et al.,
2005a). In contrast, QD 565 and QD 655 coated with
carboxylic acids or PEG-amines exhibited colocalization,
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Figure 5. IL-6 release at 24 and 48 hours. (a) Effect of 5% (v/v) water or borate vehicle on IL-6 release at 24 hours. (b–d) HEKs were treated with 5% (v/v)
of vehicle, QD 565, or QD 655 coated with PEG, PEG-amines, or carboxylic acids at 0.2 or 20 nM. (b) Twenty four hours after QD treatment; (c) Forty eight
hours after QD treatment; and (d) effect of time on IL-6 release for QD 565 and QD 655 when concentration and coating are held constant. Lower cases
a–c: significant increase (Po0.05) in IL-6 release compared to (a) vehicle-treated controls, (b) the lower doses, or (c) other coatings within each QD size.
(d) Not significantly different from 20 nM carboxylic acid-coated QDs. At 48 hours, upper case designate significant (Po0.05) differences for 20 nM
PEG-amine-coated QDs compared to (a) controls and the (b) lower dose. Number 1 represents a significant effect of QD size on IL-1b release when
concentration, time, and coating are held constant (Po0.05). (d) An asterisk denotes an effect of time on IL-6 release when concentration and coating are
held constant (Po0.05).
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which indicates cellular uptake and/or intracellular traffick-
ing of QD 565 and QD 655 of the same coating by the same
mechanisms. The result that QDs of different sizes and
coatings localized to the interior of HEKs is of importance
because it suggests a mechanism by which QDs may lodge in
the avascular epidermis and escape removal by resident
macrophages (Monteiro-Riviere and Inman, 2005).
We also observed nuclear localization of carboxylic acid
and PEG-coated QDs by live cell confocal laser scanning
microscopy, which was confirmed by TEM. Presently, it is not
known if nuclear access of the QDs examined in this study
would cause genetic damage in HEKs. There is one report,
however, that CdSe core/ZnS shell QDs coated with biotin
can nick supercoiled DNA in an in vitro, cell-free assay
(Green and Howman, 2005).
Agglomeration and/or adsorption of proteins in the culture
medium could modulate QD uptake into cells. TEM revealed
agglomeration of QDs within HEKs. Agglomeration may
occur in the culture medium as a result of nanoparticle
interaction with media salts or proteins (Borm et al., 2006),
which in the case of partially defined keratinocyte growth
medium-2 (KGM-2) medium are human epidermal growth
factor, insulin, transferrin and peptide hormones, and
proteins from bovine pituitary extract. Alternatively, agglom-
eration may take place in cytoplasmic vacuoles. However,
where agglomeration occurs, QDs were clearly available to
the cell for uptake, as evidenced by the presence of these
agglomerates in vacuoles and free in the cytoplasm for all
QDs. Observation of free QDs in the cytoplasm is an
important result, suggesting that QDs can escape cytoplasmic
vacuoles or elude sequestration, which might allow interac-
tions with cellular organelles or access to the nucleus.
Occasionally, we noted the presence of lipid droplets
peppered with electron-dense, PEG- and PEG-amine-coated
QDs within the interior and along the periphery of the
lipid droplet. Such lipids droplets are normally present in
HEKs.
Cell viability dose–response assays showed significant
cytotoxicity for PEG-amine- and carboxylic acid-coated QDs,
but not PEG-coated QDs. These results were consistent
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Figure 6. IL-8 release at 24 and 48 hours. (a) Effect of 5% (v/v) water or borate vehicle on IL-8 release at 24 hours. (b–d) HEKs were treated with 5% (v/v) of
vehicle, QD 565, or QD 655 coated with PEG, PEG-amines, or carboxylic acids at 0.2 or 20 nM. (b) Twenty four hours after QD treatment; (c) Forty eight
hours after QD treatment; and (d) effect of time on IL-8 release for QD 565 and QD 655 when concentration and coating are held constant. Lower cases
a–c: significant increase (Po0.05) in IL-8 release compared to (a) vehicle-treated controls, (b) the lower doses, or (c) other coatings within each QD size.
At 48 hours, upper case designate significant (Po0.05) differences for 20 nM PEG-amine-coated QDs compared to (A) controls and the (B) lower dose.
Number 1 represents a significant effect of QD size on IL-8 release when concentration, time, and coating are held constant (Po0.05). (d) An asterisk denotes
an effect of time on IL-8 release when concentration and coating are held constant (Po0.05).
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for QDs of both sizes. PEG-coated QD 565 and QD
655 exhibited no appreciable cytotoxicity over 48 hours,
but PEG-amine and carboxylic acid-coated QD 565 and QD
655 exhibited significant cytotoxicity within 48 hours at the
highest dose. A modulatory role for exposure time in QD
cytotoxicity was demonstrated by comparison of PEG-amine-
coated QD 565 and QD 655 at 24 and 48 hours. No
decreases in cell viability were observed at 24 hours, but cell
viability had decreased significantly by 48 hours in both
cases. We also observed a modest but significant effect of QD
size on cytotoxicity when carboxylic acid-coated QD 655
exhibited an increase in cytotoxicity between 24 and
48 hours that was greater in magnitude than that observed
for QD 565 with the same coating. The cytotoxicity of
compositionally diverse QDs has been investigated in multi-
ple cell lines and at multiple end points (Hardman, 2006;
Monteiro-Riviere and Ryman-Rasmussen, 2006). Assessment
of QD cytotoxicity at the MTT end point has been reported in
several cell lines (Derfus et al., 2004; Shiosahara et al., 2004;
Lovric et al., 2005a, b), but the mechanisms underlying
cytotoxicity have not been defined. Hypothesized mechan-
isms include oxidative stress as a result of QD-mediated
reactive oxygen species production (Lovric et al., 2005b) and
leaching of core metals into the culture medium (Derfus
et al., 2004). Metal leaching from the core is an unlikely
mechanism of toxicity in the present study because core
composition was controlled (i.e. these QDs differed only in
surface coating) and the CdSe core of all QDs were ‘‘capped’’
with ZnS, which has been shown to attenuate leaching
(Derfus et al., 2004). Oxidative stress as a result of reactive
oxygen species production cannot be ruled out, but does not
directly address the clear effect of QD coating on HEK
viability that we observed.
Before this work, inflammatory responses to QDs had not
been explored. QDs and other nano-sized structures are
expected to have high inflammatory potential owing to a
large surface area to volume ratio (Oberdorster et al., 2005).
This expectation is based upon immune responses of the lung
following exposure to airborne particulate matter, which has
shown the greatest infiltration of immune cells for ultrafine
(nano-sized) versus larger particles (Oberdorster, 2001).
Immune responses of skin are substantially mediated by
epidermal keratinocytes, which upon activation by environ-
mental stimuli, secrete proinflammatory cytokines (Barker
et al., 1991; Nickoloff, 1991). Previous studies in our
laboratory have shown that IL-8 is a suitable biomarker for
cutaneous inflammation in response to diverse chemicals and
chemical mixtures (Allen et al., 2000, 2001; Chou et al.,
2002; Chou et al., 2003; Monteiro-Riviere et al., 2003; ). The
cytokines selected for the present study are broad markers for
keratinocyte-mediated inflammation. Levels of all cytokines
were normalized to the MTT viability data to account for
reduced cell number resulting from cytotoxicity. We ob-
served a robust effect of coating on cytokine release in
response to QDs. This effect was consistent across two sizes
of QDs and for three different cytokines. Carboxylic acid-
coated QDs of both sizes increased release of IL-1b, IL-6, and
IL-8 2- to 5-fold over 48 hours, whereas PEG-coated QDs
exhibited no increase in cytokine release and PEG-amine-
coated QDs exhibited only a slight increase in IL-6 and IL-8.
Modulatory effects of time and size on cytokine release for
carboxylic acid-coated QDs were noted when carboxylic
acid-coated QD 565 showed a 2-fold increase in IL-6 and
IL-8 release at 24 hours that did not increase between 24 and
48 hours, but carboxylic acid-coated QD 655 did not cause
significant elevations in IL-6 and IL-8 until 48 hours, at which
time the magnitude of release was similar to that of QD 565.
Also, both carboxylic acid-coated QD 565 and QD 655
showed a 2- to 3-fold increase in the release of IL-1b at
24 hours. By 48 hours, however, the magnitude of IL-1b
release for QD 655 was 2.5-fold greater than that of QD 565,
which remained at levels similar to the 24 hours time point.
Thus, a 24 hours delay in maximal cytokine release for
carboxylic acid-coated QD 655 relative for QD 565 was
observed for all three cytokines. Also of consideration is the
contribution of delivery vehicles to the inflammatory
response. Although we saw no effects of the QD vehicles
used herein on proinflammatory cytokine release, we have
observed modulation of multi-walled carbon nanotubes-
mediated IL-8 release in HEKs when delivered in pluronic
surfactant vehicles (Monteiro-Riviere et al., 2005a).
Table 1. Summary of QD effects in HEK.
Cytotoxicity IL-1b IL-6 IL-8
QD 565PEG
24 h NS NS NS NS
48 h NS NS NS NS
QD 565PEGNH2
24 h NS NS NS NS
48 h +++ NS + +
QD 565COOH
24 h +++ +++ ++ +++
48 h +++ +++ ++ +++
QD 655PEG
24 h NS NS NS NS
48 h + NS NS NS
QD 655PEGNH2
24 h NS NS NS NS
48 h +++ NS NS +
QD 655COOH
24 h +++ +++ NS NS
48 h ++++ ++++ +++ +++
HEK, human epidermal keratinocytes; NS, not significant; QD, quantum
dots.
Relative degree of effect within each column indicated by (+) or NS.
Effects range from (+): statistically significant, but small in magnitude to
(++++): statistically significant and large in magnitude.
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The present study suggests that the surface charge of the
QDs, whether cationic or anionic, is an important variable for
QD cytotoxicity and inflammation, with the cationic
carboxylic acid-coated QDs showing the highest potential.
This could be secondary to altered cellular localization of
charged QDs or increased sensitivity of target site to these
particles. This phenomenon, now recognized by this
research, deserves further study. It is also of relevance for
risk assessment in the light of evidence that QDs can
penetrate the outer stratum corneum barrier of intact skin.
Previously, we used these same QDs to show that topically
applied QD 565 and QD 655 coated with PEG, PEG-amine,
and carboxylic acids localized within the epidermis or dermis
by 8 hours for all but carboxylic acid-coated QD 655, which
localized primarily in the epidermis by 24 hours. Fluores-
cence intensity maps indicated a passive mechanism of
penetration (Ryman-Rasmussen et al., 2006). Recently, QDs
have been shown to penetrate porcine skin within minutes
when low frequency sonophoresis is applied (Paliwal et al.,
2006). Although the diffusion cell model utilized in both
studies provided evidence that exposure to QDs can result in
skin penetration, it does not address whether such exposures
would cause skin irritation or damage. When our previous
observation that carboxylic acid-coated QDs localize in the
epidermis (Ryman-Rasmussen et al., 2006) are considered in
conjunction with the observation of cellular uptake in the
present study, the tendency of carboxylic acid-coated QDs to
localize in the epidermis may be secondary to the tendency
for these QDs to preferentially accumulate in the keratino-
cyte. The present, in vitro study was conducted at QD
concentrations 50- to 5,000-fold lower than the 1 mM
concentration we used for the dermal penetration study.
The QDs tested herein are supplied at concentrations of up to
8.7 mM, which corresponds to human exposure concentra-
tions that are up to 400- to 40,000-fold greater than those
used in the present study. Thus, the concentrations at which
we observed QD uptake, cytotoxic effects, and inflammatory
cytokine release are arguably not supraphysiological, but
within a reasonable range for human skin exposure to QDs as
commercially supplied. Our results indicated potential for
QDs coated with carboxylic acids in particular to cause
cytotoxicity and cutaneous inflammation in vivo. Again,
these are the same QDs in which we had observed primarily
epidermal localization in our previous skin penetration study
(Ryman-Rasmussen et al., 2006). Cutaneous inflammation
can be restricted to the site of entry or, as in the case of
topical exposure to JP-8, also result in systemic modulation of
immune function (Ullrich, 1999).
Our observation of QD uptake by HEKs at low, non-
cytotoxic concentrations for all sizes and coatings begs the
question of what the long-term effects of prolonged retention
of QDs in HEKs might be. Particularly of importance is that
uptake of QDs by HEKs was not selective because QDs were
not ‘‘targeted’’ for cellular uptake by attachment to targeting
peptides or antibodies, yet intracellular and intranuclear QD
localization was observed. This suggests that QDs engineered
to function as drug delivery vectors or diagnostic agents at
other somatic sites may be non-selectively taken up by skin
cells, possibly resulting in side effects or cytotoxicity and
immunogenicity in skin.
In summary, this study showed a clear role for surface
coating in cytotoxicity and immunotoxicity that was con-
sistent across two sizes. This study expanded our previous
observations that dermal exposure to QDs results in skin
penetration by showing that select QDs may pose an
acute dermal hazard of cytotoxicity and inflammation,
depending upon surface coating. Cytotoxic and inflammatory
effects of QD surface coatings may extend to other
families of engineered nanoparticles, which argues for
the utility of QDs as important models for toxic responses
of skin to nanoparticles with industrial and medical
applications.
MATERIALS AND METHODS
Quantum dots
QDs with a CdSe core and ZnS shell of two different sizes were
obtained from Quantum Dot Corporation/Invitrogen (Hayward, CA).
QDs with fluorescence emission maxima at 565 nm (QD 565) have a
spherical core/shell with a diameter of 4.6 nm. QDs with emission
maxima at 655 nm (QD 655) have an ellipsoid core/shell with
diameters of 6 nm (minor axis) by 12 nm (major axis) (Quantum Dot
Corporation, 2005, personal communication). Each size was
obtained with three different surface coatings: PEG, PEG-amine, or
polyacrylic acid (carboxylic acids). These coatings are, respectively,
neutral, positive, or negatively charged as supplied and at
physiological pH. The hydrodynamic diameters of QD 565 as
supplied were 35 nm (PEG), 15 nm (PEG-amine), and 14 nm
(carboxylic acid). The hydrodynamic diameters (major axis) of QD
655 were 45 nm (PEG), 20 nm (PEG-amine), and 18 nm (carboxylic
acid) (Quantum Dot Corporation, 2005, personal communication).
QDs were sold as Qtrackers Non-targeted Quantum Dots (PEG) or
Qdots ITKTM Amino (PEG) or Carboxyl QDs, respectively. QDs
were supplied at concentrations ranging from 2 to 8.7 mM in a 50 mM
borate buffer of pH 9.0 (carboxylic acid-coated QDs) or pH 8.3 (PEG
and PEG-amine-coated QDs).
Cell culture and QD treatment
CloneticsTM cryopreserved primary HEKs were grown at 371C and
5% CO2 in KGM-2 medium according to the manufacturer’s
instructions (Cambrex Bio Science Walkersville Inc., Walkersville,
MD) and were passaged twice before the start of experiments.
Ninety-six-well microplates were coated with 100 ml of 0.1 mg/ml rat
tail collagen Type I (BD Biosciences, Bedford, MA) in 20 mM acetic
acid for 1 hour and rinsed with two volumes of calcium-free Hank’s
balanced salt solution (HBSS) before use. Diameter glass bottom
culture dishes (35 mm) (WillCo Wells B.V., Amsterdam, The
Netherlands) were coated with 1 ml of 0.1 mg/ml collagen for 1 hour
and rinsed with two volumes of HBSS before use. Twenty-five cm2
flasks were coated with 2 ml of 0.1 mg/ml collagen for 1 hour and
rinsed with two volumes of HBSS before use. HEKs were plated at
1.5–2.0 104 cells/cm2 and were grown to 40–60% confluency
before QD treatment. As QDs of different coatings are supplied at
different concentrations in borate buffers, it is critical that the final
concentration of borate ions be the same after dilution into culture
medium. QDs were vortexed for 1 minute to ensure complete
suspension before dilution into borate buffer vehicle of the
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appropriate pH (8.3 or 9.0) to 20 times the desired, final
concentration. Diluted QDs were then immediately added to
KGM-2 medium, and vortexed. The final concentration of borate
in the medium was 0.5 mM and comprised 5% of the total volume.
Vehicle-treated controls similarly contained 0.5 mM borate buffer of
the appropriate pH comprising 5% of the total volume. Addition of
water or borate vehicle (pH 8.3 or 9.0) to 5% (v/v) in KGM-2 does
not change the pH of the medium.
Medium in 96-well plates (for MTT viability and cytokine assays)
was replaced with 150ml of borate vehicle- or QD-containing
medium. The final QD concentration was 0.2, 2, or 20 nM. QDs in
culture medium were incubated with cells for 24 or 48 hours.
Dual label samples containing both QD 565 and QD 655 for live
cell confocal studies were prepared to minimize the possibility of co-
agglomeration. QDs were individually diluted in borate buffer
vehicle of the appropriate pH and added to KGM-2 to a final
concentration of 4 nM. Equal volumes of 4 nM QD 565 and QD 655
with the same surface coating (PEG, carboxylic acids, or PEG-
amines) were mixed to a final concentration of 2 nM each of QD565
and QD 655. The medium in 35 mm glass bottom culture dishes was
replaced with 2 ml of KGM-2 containing the borate buffer vehicle
controls or 2 nM QD 565 and QD 655 and incubated for 24 hours
before live cell confocal imaging.
HEKs were plated in 25 cm2 flasks for TEM. Cells were treated
with 2 nM QD 565 or QD 655 of each coating or with borate buffer
vehicle controls for 24 hours before processing for TEM.
Laser scanning confocal microscopy of QDs in live HEKs
After 24 hours of dosing with QDs, 35 mm culture dishes were rinsed
three times with 2 ml of HBSS and the medium replaced with 2 ml
pre-warmed KGM-2. Culture dishes were mounted on a stage
attached to an INC-2000 incubator system (20/20 Technology Inc.,
Wilmington, NC) with a 371C humidified chamber and CO2 line.
QDs were imaged in live cells using a Nikon C1 confocal laser
scanner connected to a Nikon Eclipse 2000E inverted fluorescence
microscope with a  40 Plan Fluor ELWD (dry) objective (0.60 NA).
QDs were excited with a 488 nm Ar laser line with filter-based
emission channels of 565–615 nm (QD 565) and 630 nm and above
(QD 655). Confocal-DIC images of HEK cells were obtained by
excitation with a 633 nm HeNe laser line. Images were captured
using Nikon EZ-C1 software (version 2.01.152). The full cellular
thickness (approximately 30 mM) was scanned in 1mM steps. Interior
images were chosen to show QD subcellular localization. All
imaging data are representative of three similar experiments
conducted on different days.
TEM of QDs in HEKs
After 24 hours incubation with 2 nM QDs, medium was removed,
cells were rinsed three times with two volumes of HBSS, and fixed in
Trump’s fixative at 41C. HEKs were harvested by scraping into 1.5 ml
microfuge tubes followed by centrifugation at 14,000 g. Cell
pellets were embedded in 3% agar and post-fixed for 1 hour at 41C in
1% osmium tetroxide. Samples were dehydrated in increasing
concentrations of ethanol, cleared in acetone, and embedded in
Spurr’s resin. Thin sections were mounted on copper grids
and examined on a Phillips Em208S TEM. Imaging data represent
two separate experiments of 1–2 replicates for each QD size and
coating.
MTT cell viability assays
An MTT assay was used to assess cell viability after 24 or 48 hours of
QD treatment. Cell culture medium containing QDs was removed
and 200 ml of 0.5 mg/ml 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-
2H-tetrazolium bromide (Sigma-Aldrich, St Louis, MO) in KGM-2
was added to QDs and vehicle-treated wells. KGM-2 alone was
added to duplicate control wells that contained vehicle-treated cells.
HEKs were returned to the incubator for 3 hours. At the end of the
incubation period, the medium was removed and HEKs were rinsed
with 200 ml of HBSS for 2 minutes. The HBSS was removed by
aspiration, and 100 ml of 70% isopropanol was added to each well
and incubated for 60 minutes on a rotating platform to dissolve the
MTT. Microplates were read at 550 nm in a Multiskan microplate
spectrophotometer (Thermo LabSystems, Milford, MA) equipped
with Ascent Software (version 2.6). The average background
absorbance from control wells (KGM-2 without added MTT) was
subtracted from MTT-treated samples and data were plotted as a
percentage of the appropriate vehicle-treated control using Prism v.
4 software (Graph Pad Inc., San Diego, CA). Five replicates per data
point were used for all treatments. Data are expressed as the means
and SEs of two experiments (5% (v/v) water versus borate vehicle
controls) or 4–6 experiments (QDs versus the appropriate borate
vehicle-treated controls).
Cytokine release assays
Twenty-four hours after the addition of QDs to 96-well microplates
(N¼ 5 wells per treatment point), the culture medium was removed,
pooled into a microfuge tube, and frozen at 801C until assayed. On
the day of the assay, samples were thawed and 50ml of each sample
added (in duplicate) to a singleplex ELISA plate for human IL-8 and a
multiplex ELISA plate for human IL-1b, IL-6, IL-10, and tumor necrosis
factor-a (BioPlex Cytokine Assays, BioRad Laboratories, Hercules, CA)
and the ELISA performed according to the manufacturer’s instructions.
Samples were read on a BioPlex System (BioRad/Luminex) equipped
with BioPlex software (version 4.0). Unknowns were quantified by
linear regression to logarithmic standard curves. Cytokine levels were
normalized relative to MTT absorbance. Data were expressed as fold
over that of controls receiving the appropriate boric acid vehicle using
Prism v. 4 software (Graph Pad Inc., San Diego, CA). Data are
expressed as the means and standard errors of two experiments (5%
(v/v) water versus borate vehicle-treated controls) or 4–5 experiments
(QDs versus the appropriate borate vehicle controls).
Statistical analysis
A Kruskal–Wallis nonparametric analysis of variance was used to
compare vehicle-treated cells to cells treated with water for cell
viability and cytokine release assays. A one-way analysis of variance
was used to compare the effect of concentration on cell viability and
inflammatory cytokine release for QDs with size, surface coating,
and time held constant. Significant differences were identified via a
post hoc Tukey’s test. An effect of time on cell viability and
inflammatory cytokine release for each size/shape with surface
coating and concentration held constant was identified by using a
one-way analysis of variance followed by a post hoc Tukey’s test. An
effect of size/shape was similarly determined for the cell viability
and cytokine release data by holding concentration and time
constant. Significance for all values was set at Po0.05. All statistical
analysis was performed using Prism v. 4 software.
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